Brief: Altamira Therapeutics Completes Enrollment For COVAMID Trial With Bentrio In Acute COVID-19

Altamira Therapeutics

13/09/2022 14:26

Sept 13 (Reuters) - Altamira Therapeutics Ltd  CYTO.O :
    * ALTAMIRA THERAPEUTICS COMPLETES ENROLLMENT FOR COVAMID
TRIAL
WITH BENTRIO IN ACUTE COVID-19
    * ALTAMIRA THERAPEUTICS LTD - STUDY HAS REACHED EXTENDED
ENROLLMENT TARGET OF 160 PATIENTS
    * ALTAMIRA THERAPEUTICS LTD - TOP-LINE DATA READ-OUT
EXPECTED IN
Q4-22

Source text for Eikon:  ID:nGNX2sFVkJ 
Further company coverage:  CYTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))